Suven Pharmaceuticals Ltd - 543064 - Intimation Under Regulation 31A (8)(C) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')
Intimation under Regulation 31A(8)(c) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the earnings conference call for the quarter and half year ended September 30, 2023 Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI LODR, please find enclosed the copies of newspaper advertisement regarding notice of postal ballot. The Advertisement has appeared today i.e., November 11, 2023 in Nava Telangana (Telugu) and Business Standard. Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to regulation 47 of SEBI (LODR), please find enclosed copies of news paper advertisements regarding Financial Results of the Company for the quarter and half year ended September 30, 2023. The Advertisements has appeared in today i.e., November 11, 2023 in Andhra Prabha (Telugu) and Business Standard. Suven Pharmaceuticals Ltd - 543064 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November 10, 2023 for Berhyanda Ltd & Berhyanda Midco Ltd Suven Pharmaceuticals Ltd - 543064 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 10, 2023 for Berhyanda Ltd & Berhyanda Midco Ltd Suven Pharmaceuticals Ltd - 543064 - Post-Offer Advertisement
Kotak Mahindra Capital Company Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Post-Offer Advertisement in accordance with Regulation 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, (as amended) for the attention of the public shareholders of Suven Pharmaceuticals Ltd ("Target Company"). Suven Pharmaceuticals Ltd - 543064 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please find attached postal ballot notice dated November 09, 2023 seeking approval of members of the Company , by way of remote e-voting process for shifting of registered office of the Company from Hyderabad in the State of Telangana to Mumbai in the State of Maharashtra and consequent Amendment to Memorandum of Association of the Compaany. Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our Results conference call intimation dated November 02, 2023, that audio recording of the conference call for the quarter and half year ended September 30, 2023 held on Thursday, November 09, 2023, has been uploaded on the Company''s website at https://suvenpharm.com/financial-info/ Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Directors